4-acetamide-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(methyl acetate)oxolan-2-yl]pyrimidin-2(1H)-one
PG-20161-51847
MW 357.3
Same subcategory
PG-20161-29369
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-29369 | 10 MG | USD 141 | In stock | |
| PG-20161-29369 | 25 MG | USD 169 | In stock | |
| PG-20161-29369 | 50 MG | USD 447 | In stock |
Prices are shown in USD. Final pricing, package availability and delivery are confirmed with your quotation.
Regadenoson is an agonist of the adenosine A2A receptor, a G-protein-coupled receptor identified as a therapeutic research target in oncology, inflammation, Parkinson's disease and cardiovascular disease. It is cataloged within Nucleic Acid Chemistry under modified nucleosides. The compound has the molecular formula C15H18N8O5 and a molecular weight of 390.4, with a listed storage temperature of -20°C.